UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 13, 2017
Trovagene, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-35558 |
|
27-2004382 |
(State or other jurisdiction |
|
(Commission File |
|
IRS Employer |
of incorporation or organization) |
|
Number) |
|
Identification No.) |
11055 Flintkote Avenue
San Diego, CA 92121
(Address of principal executive offices)
Registrants telephone number, including area code: (858) 952-7570
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
EXPLANATORY NOTE
This current report on Form 8-K/A (the Amendment) amends the current report on Form 8-K dated June 13, 2017 filed by Trovagene, Inc. (the Company) with the U.S. Securities and Exchange Commission on June 13, 2017 (the Original Form 8-K). The Original Form 8-K reported the final voting results of the Companys 2017 Annual Meeting of Stockholders held on June 13, 2017 (the 2017 Annual Meeting). The sole purpose of this Amendment is to change the outcome of the voting for Proposal 3 which was approved by the Companys stockholders.. No other changes have been made to the Original Form 8-K.
Item 5.07 Submission of Matters to a Vote of Security Holders
Proposal 3. The adoption of an amendment to the Companys 2014 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder to 9,500,000 from 7,500,000 was approved by the stockholders by the votes set forth in the table below:
For |
|
Against |
|
Abstain |
|
Broker Non Vote |
3,389,123 |
|
2,234,629 |
|
40,515 |
|
13,419,401 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 23, 2017
|
TROVAGENE, INC. | |
|
| |
|
|
|
|
By: |
/s/ William J. Welch |
|
|
William J. Welch |
|
|
Chief Executive Officer |